<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art6">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73560</ArticleID>
            <ArticleDOI>10.1208/aapsj070356</ArticleDOI>
            <ArticleSequenceNumber>6</ArticleSequenceNumber>
            <ArticleTitle Language="En">Opioid peptide-derived analgesics</ArticleTitle>
            <ArticleFirstPage>E560</ArticleFirstPage>
            <ArticleLastPage>E565</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>5</Month>
                <Day>27</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>6</Month>
                <Day>27</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Peter</GivenName>
                  <GivenName>W.</GivenName>
                  <FamilyName>Schiller</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(514) 987-5576</Phone>
                  <Fax>(514) 987-5513</Fax>
                  <Email>schillp@ircm.qc.ca</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Laboratory of Chemical Biology and Peptide Research</OrgDivision>
                <OrgName>Clinical Research Institute of Montreal</OrgName>
                <OrgAddress>
                  <Street>110 Pine Avenue West</Street>
                  <Postcode>H2W 1R7</Postcode>
                  <City>Montreal</City>
                  <State>Quebec</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Two recent developments of opioid peptide-based analgesics are reviewed. The first part of the review discusses the dermorphin-derived, cationic-aromatic tetrapeptide H-Dmt-D-Arg-Phe-Lys-NH<Subscript>2</Subscript> ([Dmt<Superscript>1</Superscript>]DALDA, where Dmt indicates 2′,6′-dimethyltyrosine), which showed subnanomolar μ receptor binding affinity, extraordinary μ receptor selectivity, and high μ agonist potency in vitro. In vivo, [Dmt<Superscript>1</Superscript>]DALDA looked promising as a spinal analgesic because of its extraordinary antinociceptive effect (3000 times more potent than morphine) in the mouse tail-flick assay, long duration of action (4 times longer than morphine), and lack of effect on respiration. Unexpectedly, [Dmt<Superscript>1</Superscript>]DALDA also turned out to be a potent and long-acting analgesic in the tail-flick test when given subcutaneously (s.c.), indicating that it is capable of crossing the blood-brain barrier. Furthermore, little or no cross-tolerance was observed with s.c. [Dmt<Superscript>1</Superscript>]DALDA in morphine-tolerant mice. The second part of the review concerns the development of mixed μ agonist/δ antagonists that, on the basis of much evidence, are expected to be analgesics with a low propensity to produce tolerance and physical dependence. The prototype pseudopeptide H-Dmt-TicΨ[CH<Subscript>2</Subscript>NH]Phe-Phe-NH<Subscript>2</Subscript> (DIPP-NH<Subscript>2</Subscript>[Ψ], where Tic indicates 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid) showed subnanomolar μ and δ receptor binding affinities and the desired μ agonist/δ antagonist profile in vitro. DIPP-NH<Subscript>2</Subscript>[Ψ] produced a potent analgesic effect after intracerebroventricular administration in the rat tail-flick assay, no physical dependence, and less tolerance than morphine. The results obtained with DIPP-NH<Subscript>2</Subscript>[Ψ] indicate that mixed μ agonist/δ antagonists look promising as analgesic drug candidates, but compounds with this profile that are systemically active still need to be developed.</Para>
            </Abstract>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 14, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73560.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Pfeiffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Brantl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Herz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HM</Initials>
                    <FamilyName>Emrich</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Psychotomimesis mediated by kappa opiate receptors</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>233</VolumeID>
                  <FirstPage>774</FirstPage>
                  <LastPage>776</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3016896</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.3016896</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XltVynt7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors.<Emphasis Type="Italic">Science</Emphasis>. 1986;233:774–776.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Walsh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EC</Initials>
                    <FamilyName>Strain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Abreu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GE</Initials>
                    <FamilyName>Bigelow</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans</ArticleTitle>
                  <JournalTitle>Psychopharmacology (Berl)</JournalTitle>
                  <VolumeID>157</VolumeID>
                  <FirstPage>151</FirstPage>
                  <LastPage>162</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s002130100788</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXns1Clt7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.<Emphasis Type="Italic">Psychopharmacology (Berl)</Emphasis>. 2001;157:151–162.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Yaksh</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">In vivo studies on spinal opiate receptor systems mediating antinociception, I: mu and delta receptor profiles in the primate</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>226</VolumeID>
                  <FirstPage>303</FirstPage>
                  <LastPage>316</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6308205</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3sXlsFart78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception, I: mu and delta receptor profiles in the primate.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1983;226:303–316.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Mosberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hurst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Burks</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>230</VolumeID>
                  <FirstPage>341</FirstPage>
                  <LastPage>348</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6086883</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXlsVCjsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1984;230:341–348.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cowan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XZ</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Mosberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Omnaas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Direct dependence studies in rats with agents selective for different types of opioid receptor</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>246</VolumeID>
                  <FirstPage>950</FirstPage>
                  <LastPage>955</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2901490</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1cXmtVGitrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F. Direct dependence studies in rats with agents selective for different types of opioid receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1988;246:950–955.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PY</Initials>
                    <FamilyName>Cheng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Decena</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Soong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>McCabe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Opioid-induced stimulation of fetal respiratory activity by [D-Ala<Superscript>2</Superscript>]deltorphin, I</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>230</VolumeID>
                  <FirstPage>85</FirstPage>
                  <LastPage>88</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8381356</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(93)90413-C</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXhsVShtrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cheng PY, Wu D, Decena J, Soong Y, McCabe S, Szeto HH. Opioid-induced stimulation of fetal respiratory activity by [D-Ala<Superscript>2</Superscript>]deltorphin, I.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1993;230:85–88.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Galligan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Mosberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hurst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TF</Initials>
                    <FamilyName>Burks</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>229</VolumeID>
                  <FirstPage>641</FirstPage>
                  <LastPage>648</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6327967</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXkvVersb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Galligan JJ, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1984;229:641–648.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SJ</Initials>
                    <FamilyName>Weber</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Greene</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Sharma</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Distribution and analgesia of [<Superscript>3</Superscript>H][D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin and two halogenated analogs after intravenous administration</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>259</VolumeID>
                  <FirstPage>1109</FirstPage>
                  <LastPage>1117</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1762065</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XksVSrs7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weber SJ, Greene DL, Sharma SD, et al. Distribution and analgesia of [<Superscript>3</Superscript>H][D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin and two halogenated analogs after intravenous administration.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1991;259:1109–1117.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CI</Initials>
                    <FamilyName>Svensson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Rew</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Malkmus</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Systemic and spinal analgesic activity of a δ-opioid-selective lanthionine enkephalin analog</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>827</FirstPage>
                  <LastPage>832</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12538839</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.039750</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXpvVCltw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Svensson CI, Rew Y, Malkmus S, et al. Systemic and spinal analgesic activity of a δ-opioid-selective lanthionine enkephalin analog.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:827–832.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kamei</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Saitoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ohsawa</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Antinociceptive effects of the selective non-peptidic δ-opioid receptor antagonist TAN-67 in diabetic mice</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>276</VolumeID>
                  <FirstPage>131</FirstPage>
                  <LastPage>135</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7781682</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(95)00026-H</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXksVyrs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kamei J, Saitoh A, Ohsawa M, et al. Antinociceptive effects of the selective non-peptidic δ-opioid receptor antagonist TAN-67 in diabetic mice.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1995;276:131–135.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K-J</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GC</Initials>
                    <FamilyName>Rigdon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Howard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>McNutt</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>267</VolumeID>
                  <FirstPage>852</FirstPage>
                  <LastPage>857</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8246159</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXksFyisQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chang K-J, Rigdon GC, Howard JL, McNutt RW. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1993;267:852–857.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SN</Initials>
                    <FamilyName>Calderon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Porreca</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Probes for narcotic receptor mediated phenomena, 19: synthesis of (+)-4-(αR)-α-((2S, 5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80): a highly selective, nonpeptide delta opioid receptor agonist</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>2125</FirstPage>
                  <LastPage>2128</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8035418</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00040a002</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXltVyksr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Calderon SN, Rothman RB, Porreca F, et al. Probes for narcotic receptor mediated phenomena, 19: synthesis of (+)-4-(αR)-α-((2S, 5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80): a highly selective, nonpeptide delta opioid receptor agonist.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1994;37:2125–2128.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Plobeck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Delorme</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z-Y</Initials>
                    <FamilyName>Wei</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">New diarylmethylpiperazines as potent and selective nonpeptidic δ opioid receptor agonists with increased in vitro metabolic stability</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <FirstPage>3878</FirstPage>
                  <LastPage>3894</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11052793</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm000228x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmsFeitLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Plobeck N, Delorme D, Wei Z-Y, et al. New diarylmethylpiperazines as potent and selective nonpeptidic δ opioid receptor agonists with increased in vitro metabolic stability.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2000;43:3878–3894.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>DeHaven-Hudkins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RE</Initials>
                    <FamilyName>Dolle</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Peripherally restricted opioid agonists as novel analgesic agents</ArticleTitle>
                  <JournalTitle>Curr Pharm Des</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>743</FirstPage>
                  <LastPage>757</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15032700</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1381612043453036</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhvFOktbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>DeHaven-Hudkins DL, Dolle RE. Peripherally restricted opioid agonists as novel analgesic agents.<Emphasis Type="Italic">Curr Pharm Des</Emphasis>. 2004;10:743–757.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM-D</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NN</Initials>
                    <FamilyName>Chung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lemieux</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Dermorphin analogues carrying an increased positive net charge in their “message” domain display extremely high μ-opioid receptor selectivity</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>698</FirstPage>
                  <LastPage>703</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2537427</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm00123a035</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhtFGgsLk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Nguyen TM-D, Chung NN, Lemieux C. Dermorphin analogues carrying an increased positive net charge in their “message” domain display extremely high μ-opioid receptor selectivity.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1989;32:698–703.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM-D</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Berezowska</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Synthesis and in vitro opioid activity profiles of DALDA analogues</ArticleTitle>
                  <JournalTitle>Eur J Med Chem</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>895</FirstPage>
                  <LastPage>901</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11121615</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0223-5234(00)01171-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXovFaitLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Nguyen TM-D, Berezowska I, et al. Synthesis and in vitro opioid activity profiles of DALDA analogues.<Emphasis Type="Italic">Eur J Med Chem</Emphasis>. 2000;35:895–901.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Neilan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM-D</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GW</Initials>
                    <FamilyName>Pasternak</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Pharmacological characterization of the dermorphim analog [Dmt<Superscript>1</Superscript>]DALDA, a highly potent and selective μ-opioid peptide</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>419</VolumeID>
                  <FirstPage>15</FirstPage>
                  <LastPage>23</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11348625</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0014-2999(01)00946-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjtlChtLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Neilan CL, Nguyen TM-D, Schiller PW, Pasternak GW. Pharmacological characterization of the dermorphim analog [Dmt<Superscript>1</Superscript>]DALDA, a highly potent and selective μ-opioid peptide.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 2001;419:15–23.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Neilan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Janvey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Bolan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Characterization of the binding of [<Superscript>3</Superscript>H][Dmt<Superscript>1</Superscript>]H-Dmt-D-Arg-Phe-Lys-NH<Subscript>2</Subscript>, a highly potent opioid peptide</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>306</VolumeID>
                  <FirstPage>430</FirstPage>
                  <LastPage>436</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12663687</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.103.049742</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlslGlt7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Neilan CL, Janvey AJ, Bolan E, et al. Characterization of the binding of [<Superscript>3</Superscript>H][Dmt<Superscript>1</Superscript>]H-Dmt-D-Arg-Phe-Lys-NH<Subscript>2</Subscript>, a highly potent opioid peptide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;306:430–436.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Lovelace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Fridland</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">In vivo pharmacokinetics of selective μ-opioid peptide agonists</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>298</VolumeID>
                  <FirstPage>57</FirstPage>
                  <LastPage>61</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11408525</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXksFCht7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Szeto HH, Lovelace JL, Fridland G, et al. In vivo pharmacokinetics of selective μ-opioid peptide agonists.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;298:57–61.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Shimoyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Shimoyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G-M</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH<Subscript>2</Subscript> (DALDA) and [Dmt<Superscript>1</Superscript>]DALDA</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>297</VolumeID>
                  <FirstPage>364</FirstPage>
                  <LastPage>371</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11259564</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXisVSrtrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Shimoyama M, Shimoyama N, Zhao G-M, Schiller PW, Szeto HH. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH<Subscript>2</Subscript> (DALDA) and [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2001;297:364–371.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Reimann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Schlutz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Selve</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat</ArticleTitle>
                  <JournalTitle>Anesth Analg</JournalTitle>
                  <VolumeID>88</VolumeID>
                  <FirstPage>141</FirstPage>
                  <LastPage>145</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9895081</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00000539-199901000-00026</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmtVequg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Reimann W, Schlutz H, Selve N. The antinociceptive effects of morphine, desipramine, and serotonin and their combinations after intrathecal injection in the rat.<Emphasis Type="Italic">Anesth Analg</Emphasis>. 1999;88:141–145.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Soong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Qian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G-M</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt<Superscript>1</Superscript>]DALDA</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>305</VolumeID>
                  <FirstPage>696</FirstPage>
                  <LastPage>702</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12606628</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.048561</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjt12mu7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Szeto HH, Soong Y, Wu D, Qian X, Zhao G-M. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;305:696–702.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Soong</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Profound spinal tolerance after repeated exposure to a highly selective μ-opioid peptide agonist: role of δ-opioid receptors</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>302</VolumeID>
                  <FirstPage>188</FirstPage>
                  <LastPage>196</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12065716</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.302.1.188</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xlt1Snsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhao GM, Wu D, Soong Y, et al. Profound spinal tolerance after repeated exposure to a highly selective μ-opioid peptide agonist: role of δ-opioid receptors.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2002;302:188–196.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ben</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AP</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Tolerance develops in spinal cord, but not in brain with chronic [Dmt<Superscript>1</Superscript>]DALDA treatment</ArticleTitle>
                  <JournalTitle>Br J Pharmacol.</JournalTitle>
                  <VolumeID>143</VolumeID>
                  <FirstPage>987</FirstPage>
                  <LastPage>993</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15557286</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.bjp.0706007</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhvFWlsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ben Y, Smith AP, Schiller PW, Lee NM. Tolerance develops in spinal cord, but not in brain with chronic [Dmt<Superscript>1</Superscript>]DALDA treatment.<Emphasis Type="Italic">Br J Pharmacol.</Emphasis> 2004;143:987–993.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CL</Initials>
                    <FamilyName>Neilan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>King</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Rossi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Differential sensitivities of mouse strains to morphine and [Dmt<Superscript>1</Superscript>]DALDA analgesia</ArticleTitle>
                  <JournalTitle>Brain Res</JournalTitle>
                  <VolumeID>974</VolumeID>
                  <FirstPage>254</FirstPage>
                  <LastPage>257</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12742645</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-8993(03)02590-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjs1CktLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Neilan CL, King MA, Rossi G, et al. Differential sensitivities of mouse strains to morphine and [Dmt<Superscript>1</Superscript>]DALDA analgesia.<Emphasis Type="Italic">Brain Res</Emphasis>. 2003;974:254–257.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Riba</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ben</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM-D</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Furst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">[Dmt<Superscript>1</Superscript>]DALDA is highly selective and potent at μ opioid receptors, but is not cross-tolerant with systemic morphine</ArticleTitle>
                  <JournalTitle>Curr Med Chem</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>31</FirstPage>
                  <LastPage>39</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11860345</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhtlKlu7w%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Riba P, Ben Y, Nguyen TM-D, Furst S, Schiller PW, Lee NM. [Dmt<Superscript>1</Superscript>]DALDA is highly selective and potent at μ opioid receptors, but is not cross-tolerant with systemic morphine.<Emphasis Type="Italic">Curr Med Chem</Emphasis>. 2002;9:31–39.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Luo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G-M</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Transcellular transport of a highly polar 3+net charge opioid tetrapeptide</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>304</VolumeID>
                  <FirstPage>425</FirstPage>
                  <LastPage>432</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12490619</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.102.040147</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXht1Snug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhao K, Luo G, Zhao G-M, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3+net charge opioid tetrapeptide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:425–432.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Berezowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NN</Initials>
                    <FamilyName>Chung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lemieux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Zelent</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Highly potent fluorescent analogues of the opioid peptide [Dmt<Superscript>1</Superscript>]DALDA</ArticleTitle>
                  <JournalTitle>Peptides</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>1195</FirstPage>
                  <LastPage>1200</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14612191</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.peptides.2003.07.004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXovVGntrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Berezowska I, Chung NN, Lemieux C, Zelent B, Szeto HH, Schiller PW. Highly potent fluorescent analogues of the opioid peptide [Dmt<Superscript>1</Superscript>]DALDA.<Emphasis Type="Italic">Peptides</Emphasis>. 2003;24:1195–1200.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EE</Initials>
                    <FamilyName>Abdelhamid</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Sultana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Takemori</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>258</VolumeID>
                  <FirstPage>299</FirstPage>
                  <LastPage>303</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1649297</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3MXlt1Krur4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1991;258:299–303.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Fundytus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Shapiro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Coderre</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The highly selective δ-opioid antagonist H-Tyr-Ticφ[CH<Subscript>2</Subscript>-NH]Phe-Phe-OH (TIPP[φ]) attenuates morphine tolerance and dependence</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>286</VolumeID>
                  <FirstPage>105</FirstPage>
                  <LastPage>108</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8566146</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(95)00554-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXpt1alu7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fundytus ME, Schiller PW, Shapiro M, Weltrowska G, Coderre TJ. The highly selective δ-opioid antagonist H-Tyr-Ticφ[CH<Subscript>2</Subscript>-NH]Phe-Phe-OH (TIPP[φ]) attenuates morphine tolerance and dependence.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1995;286:105–108.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Danks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Jacobson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Burke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Holaday</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Morphine tolerance increases mu-noncompetitive delta binding sites</ArticleTitle>
                  <JournalTitle>Eur J Pharmacol</JournalTitle>
                  <VolumeID>124</VolumeID>
                  <FirstPage>113</FirstPage>
                  <LastPage>119</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3013657</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-2999(86)90130-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XktFygurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rothman RB, Danks JA, Jacobson AE, Burke TRJr, Rice KE, Holaday JW. Morphine tolerance increases mu-noncompetitive delta binding sites.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1986;124:113–119.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RY</Initials>
                    <FamilyName>Yukhananov</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PM</Initials>
                    <FamilyName>Klodt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Riva</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SV</Initials>
                    <FamilyName>Zeitsev</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AI</Initials>
                    <FamilyName>Masky</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Opiate withdrawal correlates with the presence of DSLET high-affinity binding</ArticleTitle>
                  <JournalTitle>Pharmacol Biochem Behav</JournalTitle>
                  <VolumeID>49</VolumeID>
                  <FirstPage>1109</FirstPage>
                  <LastPage>1112</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7886084</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0091-3057(94)90273-9</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXitlCiu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yukhananov RY, Klodt PM, Riva AD, Zeitsev SV, Masky AI. Opiate withdrawal correlates with the presence of DSLET high-affinity binding.<Emphasis Type="Italic">Pharmacol Biochem Behav</Emphasis>. 1994;49:1109–1112.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Kest</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CY</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GL</Initials>
                    <FamilyName>McLemore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Inturrisi</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice</ArticleTitle>
                  <JournalTitle>Brain Res Bull</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>185</FirstPage>
                  <LastPage>188</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8866695</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0361-9230(95)02092-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xhslantbg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kest B, Lee CY, McLemore GL, Inturrisi CE. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice.<Emphasis Type="Italic">Brain Res Bull</Emphasis>. 1996;39:185–188.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>King</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Schuller</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knock-out mice</ArticleTitle>
                  <JournalTitle>Neuron</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>243</FirstPage>
                  <LastPage>252</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10677041</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0896-6273(00)80836-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmsVOrs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhu Y, King MA, Schuller AG, et al. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knock-out mice.<Emphasis Type="Italic">Neuron</Emphasis>. 1999;24:243–252.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Gomes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Gupta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Filipovska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HH</Initials>
                    <FamilyName>Szeto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Pintar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Devi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>101</VolumeID>
                  <FirstPage>5135</FirstPage>
                  <LastPage>5139</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15044695</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.0307601101</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjsFCitrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 2004;101:5135–5139.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Freye</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Latasch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PS</Initials>
                    <FamilyName>Portoghese</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">The delta receptor is involved in sufentanil-induced respiratory depression—opioid subreceptors mediate different effects</ArticleTitle>
                  <JournalTitle>Eur J Anaesthesiol</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>457</FirstPage>
                  <LastPage>462</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1330549</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:ByyD2cbisVY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Freye E, Latasch L, Portoghese PS. The delta receptor is involved in sufentanil-induced respiratory depression—opioid subreceptors mediate different effects.<Emphasis Type="Italic">Eur J Anaesthesiol</Emphasis>. 1992;9:457–462.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Foxx-Orenstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Jin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Grider</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">5TH4 receptor agonists and delta opioid receptor antagonists act synergistically to stimulate colonic propulsion</ArticleTitle>
                  <JournalTitle>Am J Physiol</JournalTitle>
                  <VolumeID>275</VolumeID>
                  <FirstPage>G979</FirstPage>
                  <LastPage>G983</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9815027</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M%2Fjt1KgsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Foxx-Orenstein AE, Jin JG, Grider JR. 5TH4 receptor agonists and delta opioid receptor antagonists act synergistically to stimulate colonic propulsion.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1998;275:G979-G983.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TM-D</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Differential stereochemical requirements of μ vs δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>11871</FirstPage>
                  <LastPage>11875</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1334552</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.89.24.11871</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXisVOrsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Nguyen TM-D, Weltrowska G, et al. Differential stereochemical requirements of μ vs δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:11871–11875.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Fundytus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Merovitz</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The opioid μ agonist/δ antagonist DIPP-NH<Subscript>2</Subscript>[φ] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>42</VolumeID>
                  <FirstPage>3520</FirstPage>
                  <LastPage>3526</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10479285</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm980724+</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXkvVCrtL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Fundytus ME, Merovitz L, et al. The opioid μ agonist/δ antagonist DIPP-NH<Subscript>2</Subscript>[φ] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1999;42:3520–3526.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Berezowska</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">The TIPP opioid peptide family: development of δ antagonists, δ agonists and mixed μ agonist/δ antagonists</ArticleTitle>
                  <JournalTitle>Biopolymers (Peptide Science)</JournalTitle>
                  <VolumeID>51</VolumeID>
                  <FirstPage>411</FirstPage>
                  <LastPage>425</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1097-0282(1999)51:6&lt;411::AID-BIP4&gt;3.0.CO;2-Z</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjtFSqtr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Weltrowska G, Berezowska I, et al. The TIPP opioid peptide family: development of δ antagonists, δ agonists and mixed μ agonist/δ antagonists.<Emphasis Type="Italic">Biopolymers (Peptide Science)</Emphasis>. 1999;51:411–425.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Lemieux</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NN</Initials>
                    <FamilyName>Chung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A chimeric opioid peptide with mixed μ agonist/δ antagonist properties</ArticleTitle>
                  <JournalTitle>J Pept Res</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>63</FirstPage>
                  <LastPage>68</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15009527</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1399-3011.2003.00108.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXitV2msbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weltrowska G, Lemieux C, Chung NN, Schiller PW. A chimeric opioid peptide with mixed μ agonist/δ antagonist properties.<Emphasis Type="Italic">J Pept Res</Emphasis>. 2004;63:63–68.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ananthan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HS</Initials>
                    <FamilyName>Kezar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Carter</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido-and pyrimidomorphinans</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>42</VolumeID>
                  <FirstPage>3527</FirstPage>
                  <LastPage>3538</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10479286</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm990039i</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXlt1WisrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ananthan S, Kezar HS III, Carter RL, et al. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido-and pyrimidomorphinans.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1999;42: 3527–3538.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ananthan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NK</Initials>
                    <FamilyName>Khare</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Saini</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Identification of opioid ligands possessing mixed μ agonist/δ antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>1400</FirstPage>
                  <LastPage>1412</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14998329</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm030311v</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhtVGis74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ananthan S, Khare NK, Saini SK, et al. Identification of opioid ligands possessing mixed μ agonist/δ antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2004;47:1400–1412.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
